Related by context. Frequent words. (Click for all words.) 70 Drug Shows Promise 69 Renal Cell Carcinoma 68 Vandetanib 68 Improves Survival 67 metastatic colorectal 67 Meets Primary Endpoint 67 Drug Combo 67 R sorafenib tablets 67 receiving VELCADE 66 refractory chronic lymphocytic 66 content VENDOR WHITE PAPER 66 Survival Benefit 66 Cutaneous T 65 VEGFR2 inhibitor 65 Initiates Phase II 65 ® bortezomib 65 colorectal lung 65 Stomach Cancer 65 Pirfenidone 65 Bevacizumab 65 Daclizumab 64 Epratuzumab 64 Ixempra 64 TTR amyloidosis 64 Sapacitabine 64 Receives Orphan Drug Designation 64 Epidermal Growth Factor Receptor 64 Myelofibrosis 64 Eculizumab 64 lung pancreatic 64 Autoimmune Disease 64 Patient Enrollment 64 plus gemcitabine 64 Nilotinib 64 gastrointestinal mucositis 64 Myelodysplastic Syndromes 64 Gemzar ® 64 Drug Candidate 64 Glioma 63 Fast Track Status 63 ThermoDox R 63 Hepatocellular Carcinoma 63 Lung Cancer Patients 63 Dasatinib 63 Gastric Cancer 63 lymphoma leukemia 63 Metastatic Colorectal Cancer 63 Anti Tumor 63 gemcitabine chemotherapy 63 Pivotal Phase III 63 multi kinase inhibitor 63 Alemtuzumab 63 PSMA ADC 63 Copegus R 63 Advanced Prostate Cancer 63 Breast Cancer Treatment 63 Erlotinib 62 ovarian breast 62 malignant pleural mesothelioma 62 Romidepsin 62 pancytopenia 62 Mouse Model 62 Previously Treated 62 Pfizer Sutent 62 immunologic diseases 62 Golimumab 62 moderate renal impairment 62 Pivotal Phase 62 Gemcitabine 62 Torisel 62 HuMax EGFr 62 Tesetaxel 62 Zolinza 62 Panzem R 62 ixabepilone 62 Chronic Myeloid Leukemia 62 Gene Mutation 62 paroxysmal nocturnal hemoglobinuria 62 Irinotecan 62 Mucositis 62 Prostate Cancer Patients 62 pemphigus vulgaris 62 Patients Undergoing 61 rheumatoid arthritis psoriasis 61 Completes Enrollment 61 nonsmall cell lung cancer 61 Newly Diagnosed 61 Initiate Phase 61 recurrent glioblastoma 61 pertuzumab 61 Investigational Drug 61 recurrent glioblastoma multiforme 61 Endometrial Cancer 61 Etanercept 61 Elderly Patients 61 neurovascular diseases 61 Medulloblastoma 61 Clinical Trial Results 61 FDA Accepts 61 Heart Failure Patients 61 Chronic Lymphocytic Leukemia